U.S. government officials are actively exploring many avenues and authorities to reduce reliance on pharmaceutical and medical device imports. Given the attention this issue is receiving in the White House and Congress, industry players should develop proactive strategies to ensure that any government initiatives are economically feasible. Increasing a U.S. manufacturing footprint can be challenging, but there is a window right now where elected officials and policymakers are willing to support and dedicate resources to companies that can demonstrate a credible plan to strengthen their U.S. operations.

In this webinar, King & Spalding attorneys will discuss:

• U.S. trade and economic policy surrounding the global supply chain for pharmaceuticals and medical devices
• Actions and proposals by the U.S. government to reshore and strengthen domestic pharmaceutical and medical device manufacturing
• Legal and policy approaches to help reduce costs of supply chain realignment and increase demand for U.S.-origin products

For more information or to register:

Webinar is complementary and not limited to clients.